Macomics

Macomics is an immunology company with world-leading expertise in the field of macrophage biology. They are committed to developing novel, first-class immunotherapies aimed at modulating macrophages to enhance the body's immune defense against tumors.Cancer cells can evade destruction by the immune system, and tumor-associated macrophages (TAMs) are a key component of this immunosuppressive and pro-tumor ecosystem. Modulating TAMs alters the tumor microenvironment, thereby enhancing the body's ability to fight cancer. Using its proprietary technology, Macomics has identified new targets that are highly upregulated in TAMs compared to other cell types, providing an excellent opportunity for selectively targeting tumors.